株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測

Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts (2017 - 2022)

発行 Mordor Intelligence LLP 商品コード 319398
出版日 ページ情報 英文 190 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts (2017 - 2022)
出版日: 2017年01月24日 ページ情報: 英文 190 Pages
概要

世界の動物用抗感染薬市場は2014年に43億7,000万米ドルとなる見込みです。同市場は今後もCAGR8.5%で拡大し、2019年には69億2,000万米ドルに達するとみられています。動物の感染症の症例増加に対応するため、動物用抗感染薬市場は着実に成長を遂げています。

当レポートでは、世界の動物用抗感染薬市場の動向と将来予測、市場に参入する主要企業の競合環境、市場シェア、近年の動向とともにプロファイルをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品市場
  • 動物医療とヒトの医療

第3章 市場動向

  • 市場促進因子
    • ペット所有率の上昇
    • 栄養の改善
    • 食品安全に対する消費者の意識向上
    • 家畜生産の増大
    • 人畜共通感染症、食品媒介疾患
  • 市場阻害因子
    • 耕作地と水の不足
    • 耕地に関する競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 世界の動物用抗感染薬市場セグメンテーション

  • 世界の動物用抗感染薬市場:疾患別
  • 世界の動物用抗感染薬市場:種類別
    • コンパニオンアニマル
    • 家畜
  • 世界の動物用抗感染薬市場:地域別
    • 北米
    • 欧州
    • アジア太平洋地域

第5章 競合環境

  • 市場における主要参入企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携

第6章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Description

The global market for veterinary anti-infectives is estimated to be worth USD 4,298 million in 2014. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach USD 6,218 million by 2020. Global veterinary healthcare offers services and products in various segments such as vaccines, parasiticides, anti-infectives, medicinal feed additives, other pharmaceuticals, out of which anti-infectives are growing at a steady pace to combat the increasing number of infectious diseases in animals. It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.

Global Veterinary Anti-Infectives Market- Market Dynamics

The report studies various driving and restraining factors for the global veterinary anti-infectives market. Some of these are listed below.

Drivers

Increase in pet ownership

Improved nutrition

Increasing zoonotic and foodborne diseases

Restraints

Increased competition for cultivated land and cost-effective production are the major obstacles in the path of global veterinary anti-infectives market.

The report highlights the segment-wise contribution of different anti-incentives by disease, species, and geography. By type of products, the market has been segmented into marbofloxacin, florfenicol, freeze-dried ceftiofur, beta-lactams, oxytetracycline, and aminosidine; by species into companion and farm animals and by geography into North America, Asia-Pacific, Europe and Rest of World.

Some of the key players in the market are:

Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health, Inc.

Elanco

Merck

Merial (Animal Health Division of Sanofi)

What the Report Offers

Market definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the veterinary anti-infectives market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the veterinary anti-infectives market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. INTRODUCTION

  • 1.1 Market Definition
  • 1.2 Market Recent Trends

2.Market Analysis

  • 2.1 Market Animal Health Products
  • 2.2 Animal medicines vs. human Medicines

3.Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Increase in pet ownership
    • 3.1.2 Improved Nutrition
    • 3.1.3 Intensifying consumer focus on food safety
    • 3.1.4 Greater Livestock production
    • 3.1.5 Increasing Zoonotic and Foodborne Diseases
  • 3.2 Market Constraints
    • 3.2.1 Scarcity of arable land and water
    • 3.2.2 Increased competition for cultivated land
    • 3.2.3 Cost effective production
  • 3.3 Porter's Five Force Analysis
    • 3.3.1 Threat of New Entrant
    • 3.3.2 Internal Rivalry
    • 3.3.3 Buyer bargaining power
    • 3.3.4 Supplier bargaining power
    • 3.3.5 Threat of substitutes

4.Global Veterinary Anti-Infective Market Segmentation

  • 4.1 Global Veterinary Anti-infectives Market, By disease
    • 4.1.1 Marbofloxacin
    • 4.1.2 Florfenicol
    • 4.1.3 Freeze-dried ceftiofur
    • 4.1.4 Beta-lactams
    • 4.1.5 Oxytetracycline
    • 4.1.6 Aminosidine
  • 4.2 Global Veterinary Anti-Infectives Market, By species
    • 4.2.1 Companion Animals
      • 4.2.1.1Dogs
      • 4.2.1.2 Cats
      • 4.2.1.2 Horses
    • 4.2.2 Farm animal
      • 4.2.2.1 Cattle
      • 4.2.2.2 Swine
      • 4.2.2.3 Poultry
      • 4.2.2.4 Fish
      • 4.2.2.5 Sheep
  • 4.3 Global Veterinary Anti-Infectives Market Segmentation, By Geography
    • 4.3.1 North America
      • 4.3.1.1 US
      • 4.3.1.2 Mexico
      • 4.3.1.3 Canada
    • 4.3.2 Europe
      • 4.3.2.1 France
      • 4.3.2.2 Italy
      • 4.3.2.3 Germany
      • 4.3.2.4 Spain
      • 4.3.2.5 Sweden
      • 4.3.2.6 Rest of Europe
    • 4.3.3 Asia-Pacific
      • 4.3.3.1 India
      • 4.3.3.2 China
      • 4.3.3.3 Japan
      • 4.3.3.4 Rest of Asia-Pacific
    • 4.3.4 Rest of the World

5. Competitive landscape

  • 5.1 Major players in the market
  • 5.2 mergers and acquisitions
  • 5.3 New product launches
  • 5.4 Agreement, Collaborations, and Partnerships
  • 5.5 Recommendations for New players in the market
  • 5.6 Recommendations for Existing players in the market

6. Company profiles

  • 6.1 Zoetis animal healthcare
    • 6.1.1 Financial Overview
    • 6.1.2 Business overview
    • 6.1.3 Business strategies
  • 6.2 Merck
    • 6.2.1 Financial Overview
    • 6.2.2 Business overview
    • 6.2.3 Business strategies
  • 6.3 Merial (Animal Health Division Of Sanofi)
    • 6.3.1 Financial Overview
    • 6.3.2 Business overview
    • 6.3.3 Business strategies
  • 6.4 Elanco
    • 6.4.1 Financial Overview
    • 6.4.2 Business overview
    • 6.4.3 Business strategies
  • 6.5 Bayer healthcare
    • 6.5.1 Financial Overview
    • 6.5.2 Business overview
  • 6.5 3 Business strategies
  • 6.6 Ceva Animal Health, Inc.
    • 6.6.1 Financial Overview
    • 6.6.2 Business overview
    • 6.6.3 Business strategies
  • 6.7 Virbac
    • 6.7.1 Financial Overview
    • 6.7.2 Business overview
    • 6.7.3 Business strategies
  • 6.8 Boehringer Ingelheim
    • 6.8.1 Financial Overview
    • 6.8.2 Business overview
    • 6.8.3 Business strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top